AXQ Capital’s Pfizer PFE Stock Holding History

AXQ Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-25,450	Closed	-$648K	–	892
2025 Q3	$648K	Buy	25,450 +12,621	+98%	+$312K	0.25%	129
2025 Q2	$311K	Buy	+12,829	New	+$299K	0.1%	346
2023 Q3	–	Sell	-11,600	Closed	-$425K	–	565
2023 Q2	$425K	Buy	11,600 +1,200	+12%	+$46.7K	0.53%	56
2023 Q1	$424K	Sell	10,400 -12,625	-55%	-$545K	0.17%	212
2022 Q4	$1.18M	Buy	+23,025	New	+$1.1M	0.82%	17

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

AXQ Capital's PFE Position: Q4 2025 in Review

AXQ Capital sold out of Pfizer (PFE) in Q4 2025, closing a stake of 25,450 shares — an estimated $648K sold.

AXQ Capital first reported a position in PFE in Q4 2022 and held it in 5 quarters. The position peaked at $1.18M in Q4 2022. 2,914 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

AXQ Capital reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
AXQ Capital sold 25,450 Pfizer shares in Q4 2025, an estimated $648K.
AXQ Capital first reported a position in Pfizer in Q4 2022 and held it in 5 quarters.
AXQ Capital's Pfizer position peaked at $1.18M in Q4 2022.
2,914 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on AXQ Capital's 13F filing for Q4 2025, filed 10 Feb 2026.